Personalized brachytherapy dose reconstruction using deep learning.


Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
09 2021
Historique:
received: 09 06 2021
revised: 05 08 2021
accepted: 05 08 2021
pubmed: 14 8 2021
medline: 12 10 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

Accurate calculation of the absorbed dose delivered to the tumor and normal tissues improves treatment gain factor, which is the major advantage of brachytherapy over external radiation therapy. To address the simplifications of TG-43 assumptions that ignore the dosimetric impact of medium heterogeneities, we proposed a deep learning (DL)-based approach, which improves the accuracy while requiring a reasonable computation time. We developed a Monte Carlo (MC)-based personalized brachytherapy dosimetry simulator (PBrDoseSim), deployed to generate patient-specific dose distributions. A deep neural network (DNN) was trained to predict personalized dose distributions derived from MC simulations, serving as ground truth. The paired channel input used for the training is composed of dose distribution kernel in water medium along with the full-volumetric density maps obtained from CT images reflecting medium heterogeneity. The predicted single-dwell dose kernels were in good agreement with MC-based kernels serving as reference, achieving a mean relative absolute error (MRAE) and mean absolute error (MAE) of 1.16 ± 0.42% and 4.2 ± 2.7 × 10 The proposed DNN-based personalized brachytherapy dosimetry approach exhibited comparable performance to the MC method while overcoming the computational burden of MC calculations and oversimplifications of TG-43.

Sections du résumé

BACKGROUND AND PURPOSE
Accurate calculation of the absorbed dose delivered to the tumor and normal tissues improves treatment gain factor, which is the major advantage of brachytherapy over external radiation therapy. To address the simplifications of TG-43 assumptions that ignore the dosimetric impact of medium heterogeneities, we proposed a deep learning (DL)-based approach, which improves the accuracy while requiring a reasonable computation time.
MATERIALS AND METHODS
We developed a Monte Carlo (MC)-based personalized brachytherapy dosimetry simulator (PBrDoseSim), deployed to generate patient-specific dose distributions. A deep neural network (DNN) was trained to predict personalized dose distributions derived from MC simulations, serving as ground truth. The paired channel input used for the training is composed of dose distribution kernel in water medium along with the full-volumetric density maps obtained from CT images reflecting medium heterogeneity.
RESULTS
The predicted single-dwell dose kernels were in good agreement with MC-based kernels serving as reference, achieving a mean relative absolute error (MRAE) and mean absolute error (MAE) of 1.16 ± 0.42% and 4.2 ± 2.7 × 10
CONCLUSION
The proposed DNN-based personalized brachytherapy dosimetry approach exhibited comparable performance to the MC method while overcoming the computational burden of MC calculations and oversimplifications of TG-43.

Identifiants

pubmed: 34388458
pii: S0010-4825(21)00549-7
doi: 10.1016/j.compbiomed.2021.104755
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104755

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Azadeh Akhavanallaf (A)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva 4, Switzerland.

Reza Mohammadi (R)

Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Isaac Shiri (I)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva 4, Switzerland.

Yazdan Salimi (Y)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva 4, Switzerland.

Hossein Arabi (H)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva 4, Switzerland.

Habib Zaidi (H)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva 4, Switzerland; Geneva University Neurocenter, Geneva University, CH-1205, Geneva, Switzerland; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, 9700 RB, Groningen, Netherlands; Department of Nuclear Medicine, University of Southern Denmark, DK-500, Odense, Denmark. Electronic address: habib.zaidi@hcuge.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH